Today: 20 May 2026
Imperial Brands share price lifts as buyback filing lands after ex-dividend drop
20 February 2026
1 min read

Imperial Brands share price lifts as buyback filing lands after ex-dividend drop

London, Feb 20, 2026, 08:38 GMT — Regular session underway.

  • Imperial Brands shares ticked up roughly 0.6% early, recovering some ground after Thursday’s ex-dividend slide.
  • The company reported a fresh round of share buybacks set for cancellation, part of its £1.45 billion repurchase program.
  • Next up for investors: the trading update on April 14, right after the dividend record date.

Imperial Brands (IMB.L) edged up roughly 0.6% to 3,220 pence early Friday in London, just outpacing the wider UK market.

Awkward timing, though not unusual. The stock went ex-dividend on Thursday; buyers from that point miss out on the upcoming payout. That shift alone usually knocks the price down, even if everything else stays put.

Imperial’s shares trade not just on growth hopes but for income, so the calendar counts. The company is set to pay out a final dividend of 40.08 pence per share on March 31, with Feb. 20 as the record date.

Imperial reported late Thursday it snapped up 474,606 shares for an average 3,210.90 pence apiece, picking up stock anywhere from 3,188 to 3,248 pence. These shares are set to be cancelled, trimming the count of shares in issue (not counting treasury shares) to 790,606,141, according to the filing.

The buyback comes out of the £1.45 billion programme the company rolled out in October—a key tool management relies on to return cash to shareholders.

Thursday, the numbers took over—shares dropped 1.6%, settling at 3,200 pence as the stock went ex-dividend.

Buybacks help soften dips at the edges by providing consistent demand. Still, they leave a bigger question hanging for long-term investors: can pricing power continue to make up for shrinking volumes as cigarette markets reach maturity?

The company is set to deliver a trading update April 14, then will release half-year results May 12.

Imperial’s approach on cash returns lands it alongside bigger names like British American Tobacco and Philip Morris. For these firms, dividends and buybacks carry much of the equity narrative.

The downside? Still hanging over the sector. A stricter regulatory stance on nicotine, particularly for vaping, or a sudden move in excise taxes can squeeze both volumes and margins fast. When that happens, investors usually mark down the entire group at once.

Stock Market Today

  • Sea Limited (NYSE:SE) Valuation Under Scrutiny After 46% One-Year Share Decline
    May 20, 2026, 10:05 AM EDT. Sea Limited (NYSE:SE), active across e-commerce, digital financial services, and digital entertainment in Southeast Asia and Latin America, has seen its stock fall by 46.26% over the past year. Despite recent share price weakness, some analysts argue the stock trades 36.6% below a $137.64 fair value estimate, buoyed by strong revenue growth from Shopee, Monee, and Garena platforms. Key drivers include accelerating mobile internet penetration, youth digital literacy, and shifts toward cashless payments supporting loan book expansion and improved monetization. Market watchers debate whether this dip offers a buying opportunity or reflects tempered growth prospects, especially as Shopee faces competitive pressures. Investors should weigh Sea's potential for earnings growth against market realities and execution risks.

Latest articles

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

20 May 2026
Vida Global Inc. raised $15 million in its May 18 IPO, selling 3.75 million shares at $4 each, but the stock closed at $2.29 on Tuesday. CEO Lyle Pratt bought 312,900 shares for about $1.19 million, according to a Form 4 filing. Vida reported 2025 revenue of $551,383 and a net loss of $2.9 million. The company’s shares trade on NYSE American and NYSE Texas under the symbol VIDA.
TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

20 May 2026
TJX raised its fiscal 2027 sales, earnings, and buyback targets after first-quarter comparable sales rose 6% and net income hit $1.3 billion. Shares climbed 3.6% in premarket trading. The company cited higher fuel costs as a drag on its full-year forecast. Marmaxx, HomeGoods, and TJX Canada all posted strong sales growth.
ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio Faces FDA Decision on Bladder-Cancer Application, Risk Remains

20 May 2026
The FDA accepted ImmunityBio’s application to expand Anktiva’s use with BCG in papillary-only, BCG-unresponsive non-muscle invasive bladder cancer, setting a Jan. 6, 2027 decision date. ImmunityBio reported $44.2 million in first-quarter net product revenue and held $380.9 million in cash and equivalents. Shares last traded at $7.76, down 2.8%. The filing is supported by data from 80 patients in a Phase 2/3 trial.
Oracle stock price today: ORCL stays in the green as AI worries creep back in
Previous Story

Oracle stock price today: ORCL stays in the green as AI worries creep back in

Glencore stock today: Why the share price is steady after the $2 billion payout plan
Next Story

Glencore stock today: Why the share price is steady after the $2 billion payout plan

Go toTop